Advertisement
Advertisement

ERNA

ERNA logo

Ernexa Therapeutics Inc. Common Stock

6.30
USD
Sponsored
+0.12
+1.94%
Jun 24, 15:58 UTC -4
Closed
exchange

Pre-Market

6.20

-0.10
-1.67%

ERNA Earnings Reports

Positive Surprise Ratio

ERNA beat 11 of 18 last estimates.

61%

Next Report

Date of Next Report
Aug 11, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$3.36
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Ernexa Therapeutics Inc. Common Stock earnings per share and revenue

On May 05, 2026, ERNA reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -3.36 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q1 2026, Ernexa Therapeutics Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 11, 2026.
Based on -- analysts, Ernexa Therapeutics Inc. Common Stock is expected to report EPS of -$3.36 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement